HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS
LATEST UPDATES » Vol 22, No 08, August 2018 – Regenerative technology - Meat of the future       » Hunting for new drugs to treat mental illness       » Public outcry over vaccine scandal in China       » China slashes prices of cancer medicine       » AI beats human doctors       » Nerve cells found to control appetite in mice, and possibly humans      
EYE ON CHINA
Highlights from the State Technological Invention Award

To be considered for the State Technological Invention Award, the invention must fulfill the following criteria:

  1. It is new and has not yet been made public;
  2. The invention must have technical superiority and is creative.
  3. The invention creates significant economic benefits or social benefits.

Usually inventions submitted for the award consideration have already been granted patents.

This year, a new medicine, Antofloxacin Hydrochloride, led by Shanghai Institute of Materia Medica researcher YANG Yushe, received the Second Class Award.

The medicine, with almost no phototoxicity and much less cardiotoxicity than similar medicines, helps to treat various diseases related to bacterial infection. It's China's first new medicine with independent intellectual property rights since 1993.

The clinical research found that the efficacy of this medicine reached 98.8 percent, with only 1.2 per cent of patients showing side effects in IV phase clinical trials, much lower than its counterparts. By the end of 2016, the medicine had entered 150 hospitals and medical institutions in 22 provinces and municipalities and was included in the medical insurance medicine list in more than ten of these areas.

Three other agricultural inventions also won the Second Class Award in this category.

Click here for the complete issue.

NEWS CRUNCH  
news Shire, Microsoft and EURORDIS form Global Commission to accelerate time to diagnosis for children with rare diseases
news EmTech Asia explores future of life, humanity and economy
news Biology of Ageing II - Impactful Interventions
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  
COLUMNS  
Click here to receive APBN e-newsletters once a month!

APBN Editorial Calendar 2018
January:
Obesity / Outlook for 2018
February:
Searching for the fountain of youth
March:
Women in Science - Making a difference
April:
Digestive health in the 21st century - Trust your guts
May:
Dental health - The root to good health
June:
Cancer - Therapies and strategies for better patient outcomes
July:
Water management - Technologies for biotech and pharmaceutical industries
August:
Regenerative technology - Meat of the future
September:
Digital healthcare / 3D printing
October:
Bones / Breast cancer
November:
Liver health / Top science research nations & institutions
December:
AIDS / Breakthrough of the year/Emerging trends
Editorial calendar is subjected to changes.
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Lim Guan Yu
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2018 World Scientific Publishing Co Pte Ltd  •  Privacy Policy